Nuvation Bio
Stock Forecast, Prediction & Price Target

Nuvation Bio Financial Estimates

Nuvation Bio Revenue Estimates

Nuvation Bio EBITDA Estimates

Nuvation Bio Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $660.2K
Low: $660.2K
High: $660.2K
avg. 0%
Avg: $19.28M
Low: $19.28M
High: $19.28M
avg. 2821.79%
Avg: $115.65M
Low: $115.65M
High: $115.65M
avg. 499.57%
Avg: $330.77M
Low: $330.77M
High: $330.77M
avg. 185.99%
Net Income
 
% change YoY
$-79.73M
 
N/A
$-88.66M
 
-11.19%
$-75.80M
 
14.50%
Avg: $-137.13M
Low: $-109.44M
High: $-83.17M
avg. -80.90%
Avg: $-152.19M
Low: $-102.87M
High: $-94.11M
avg. -10.98%
Avg: $-70.04M
Low: $-70.04M
High: $-70.04M
avg. 53.98%
Avg: $39.39M
Low: $39.39M
High: $39.39M
avg. 156.25%
EBITDA
 
% change YoY
$-97.28M
 
N/A
$-128.69M
 
-32.28%
$-99.6M
 
22.60%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.4
 
N/A
-$0.41
 
-2.49%
-$0.35
 
14.63%
Avg: -$0.43
Low: -$0.5
High: -$0.38
avg. -21.71%
Avg: -$0.45
Low: -$0.47
High: -$0.43
avg. -5.63%
Avg: -$0.32
Low: -$0.32
High: -$0.32
avg. 28.88%
Avg: $0.18
Low: $0.18
High: $0.18
avg. 156.25%
Operating Expenses
 
% change YoY
$93.31M
 
N/A
$119.73M
 
28.30%
$99.82M
 
-16.63%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Nuvation Bio stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 29.58% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -109.44M, average is -137.13M and high is -83.17M.

What is Nuvation Bio stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 876.84% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is $660.2K, average is $660.2K and high is $660.2K.

What is Nuvation Bio stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 39.44% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.5, average is -$0.43 and high is $-0.38.

What is the best performing analyst?

In the last twelve months analysts have been covering Nuvation Bio stock. The most successful analyst is Kennen MacKay.